Novartis may divest generic unit Sandoz as price pressures mount

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY
6. NAVN
7. HUMA
8. NVDA
9. CRWV
10. CME

Go back to Novartis may divest generic unit Sandoz as price pressures mount

Novartis's (NVS) Sandoz Said Valued at Over $20 Billion as Standalone Unit - Bloomberg

October 26, 2021 12:26 PM UTC

Novartis's (NYSE: NVS) Sandoz Said Valued at Over $20 Billion as Standalone Unit - Bloomberg

Said to Pick BofA and UBS for Sale, Spinoff
... More